The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist
- 1 June 1986
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 125 (1) , 45-62
- https://doi.org/10.1016/0014-2999(86)90082-8
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Selective muscarinic receptor antagonistsTrends in Pharmacological Sciences, 1984
- Dopamine receptor agonists: Intrinsic activity vs. state of receptorJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1983
- Pharmacological properties of oxotremorine and its analogsLife Sciences, 1983
- Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterizationLife Sciences, 1982
- A review of atropinic drug effects on exploratory choice behavior in laboratory rodentsBehavioral and Neural Biology, 1982
- Effect of antinociceptive doses of oxotremorine on mouse brain acetylcholine turnover rateLife Sciences, 1980
- Utilization of sodium-dependent high affinity choline uptake as a measure of the activity of cholinergic neuronsLife Sciences, 1975
- Studies on the central antinociceptive action of cholinomimetic agentsInternational Journal of Neuropharmacology, 1969
- Cataleptic state and hypothermia in mice, caused by central cholinergic stimulation and antagonized by anticholinergic and antidepressant drugsInternational Journal of Neuropharmacology, 1968
- Cholinergic agonist-antagonist interactions on neocortical and limbic EEG activationInternational Journal of Neuropharmacology, 1967